TrialExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation2013

Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant.

Amin R Soliman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.